Clinical Trial Update: A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of Venglustat tablets on left ventricular mass index in adults with Fabry disease. The study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Venglustat (venglustat)

Snippet

Sponsor: Sanofi | Conditions: Fabry Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING